TSC2 and hepatocellular carcinoma: In vivo analysis of an HCC subcutaneous xenograft model using the TSC2 null SNU-398 cell line showed that ganetespib at usual doses had minimal effects on tumor growth both alone and in combination with rapamycin and INK 128.